← Leaderboards
Jeanne Mandelblatt
Georgetown University
$29,742,067
Attributed
$68,504,868
Total exposure
21
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$71,713,422 · 22
By mechanism
U01$32,374,212 · 5
R01$18,716,794 · 5
R35$8,959,710 · 2
U10$3,208,554 · 3
RC2$1,999,896 · 1
UC2$1,992,945 · 1
Top collaborators
- Harry De Koning22 shared
- Sandra J Lee22 shared
- Sylvia Katina Plevritis22 shared
- Amy Trentham-Dietz22 shared
- Donald A Berry13 shared
- Tim Alan Ahles10 shared
- Andrew J Saykin10 shared
- Oguzhan Alagoz9 shared
Most similar at Georgetown University
Same institution · by research overlap
- William F Lawrence$1,782,144
- Marc D Schwartz$16,557,279
- Kathryn L Taylor$9,804,663
- Joy L Pritts$186,624
- Arnold L Potosky$11,589,176
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAffectFutureMalignant Breast NeoplasmWomanResearch PersonnelInnovationBasePoliciesQuality Of LifeAgingCohortCaringLifeDiagnosisSurvivorsCancer ControlFundingDesignCostAreaCancer CareGuidelinesDecision Making
Grant awards (107)
Investigations CONNECTing Cancer and Aging (I-CONNECT)$926,951
R35 · FY2025 · CA · contact PI
Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias$782,758
R01 · FY2025 · AG
I-REACH (Infrastructure for REsearch on Cancer and Aging)$759,485
R33 · FY2025 · AG · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement$566,636
U01 · FY2025 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,508,560
U01 · FY2024 · CA
Investigations CONNECTing Cancer and Aging (I-CONNECT)$888,061
R35 · FY2024 · CA · contact PI
Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias$806,068
R01 · FY2024 · AG
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$780,419
R33 · FY2024 · AG · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,871
U01 · FY2023 · CA
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and Aging$980,446
R35 · FY2023 · CA · contact PI
Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias$892,764
R01 · FY2023 · AG
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline$595,538
R01 · FY2023 · AG · contact PI
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline$313,672
R01 · FY2023 · AG · contact PI
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$216,418
R21 · FY2023 · AG · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,664
U01 · FY2022 · CA
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline$672,095
R01 · FY2022 · AG · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2022 · CA
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$258,418
R21 · FY2022 · AG · contact PI
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women$78,000
R03 · FY2022 · CA · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - Supplement$34,980
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,967,606
U01 · FY2021 · CA
Bio-behavioral Research At The Intersection of Cancer and Aging$888,385
R35 · FY2021 · CA · contact PI
Heterogeneity in biological, physical, and cognitive aging in older breast cancer survivors and controls$885,747
R56 · FY2021 · AG
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline$579,472
R01 · FY2021 · AG · contact PI
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,963,075
U01 · FY2020 · CA
Bio-behavioral Research At The Intersection of Cancer and Aging$854,225
R35 · FY2020 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$660,984
R01 · FY2020 · CA · contact PI
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline$659,806
R01 · FY2020 · AG · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,479,651
U01 · FY2019 · CA · contact PI
Bio-behavioral Research At The Intersection of Cancer and Aging$755,708
R35 · FY2019 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$686,651
R01 · FY2019 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,740,652
U01 · FY2018 · CA · contact PI
Bio-behavioral Research At The Intersection of Cancer and Aging$912,081
R35 · FY2018 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$724,682
R01 · FY2018 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$140,400
U01 · FY2018 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,760,379
U01 · FY2017 · CA · contact PI
Bio-behavioral Research At The Intersection of Cancer and Aging$906,217
R35 · FY2017 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$757,407
R01 · FY2017 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$426,812
U01 · FY2017 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$231,108
U01 · FY2017 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,785,514
U01 · FY2016 · CA · contact PI
Bio-behavioral Research At The Intersection of Cancer and Aging$918,318
R35 · FY2016 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$836,998
R01 · FY2016 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$430,454
U01 · FY2016 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$124,854
U01 · FY2016 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,819,268
U01 · FY2015 · CA · contact PI
Bio-behavioral Research At The Intersection of Cancer and Aging$929,318
R35 · FY2015 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$590,778
U01 · FY2015 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$431,794
U01 · FY2015 · CA · contact PI
Optimizing Personalized Care Using Economic Studies of Genomic Testing: Supporting Patient-Provider$138,291
U01 · FY2015 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,314,797
U01 · FY2014 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$442,902
U01 · FY2014 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$139,021
U01 · FY2014 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,725,720
U01 · FY2013 · CA · contact PI
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE$499,722
R01 · FY2013 · CA · contact PI
OPTIMIZING PERSONALIZED CARE USING ECONOMIC STUDIES OF GENOMIC TESTING$433,832
U01 · FY2013 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,340,092
U01 · FY2012 · CA · contact PI
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE$699,465
R01 · FY2012 · CA · contact PI
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?$616,079
R01 · FY2012 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,352,685
U01 · FY2011 · CA · contact PI
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE$809,440
R01 · FY2011 · CA · contact PI
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?$623,747
R01 · FY2011 · CA · contact PI
Using Physiological Age to Predict Chemotherapy Toxicity$542,387
R01 · FY2011 · CA · contact PI
Cancer Control at the Intersection of Aging Research$160,108
K05 · FY2011 · CA · contact PI
Comparative effectiveness of breast imaging strategies in community practice$1,992,945
UC2 · FY2010 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,257,743
U01 · FY2010 · CA · contact PI
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE$833,064
R01 · FY2010 · CA · contact PI
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?$643,828
R01 · FY2010 · CA · contact PI
Using Physiological Age to Predict Chemotherapy Toxicity$577,093
R01 · FY2010 · CA · contact PI
Cancer Control at the Intersection of Aging Research$159,165
K05 · FY2010 · CA · contact PI
CISNET: The "Spectrum" of Breast Cancer Disparities$39,634
U01 · FY2010 · CA · contact PI
Comparative effectiveness of breast imaging strategies in community practice$1,999,896
RC2 · FY2009 · CA
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE$810,923
R01 · FY2009 · CA · contact PI
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?$649,884
R01 · FY2009 · CA · contact PI
Using Physiological Age to Predict Chemotherapy Toxicity$582,693
R01 · FY2009 · CA · contact PI
CISNET: The "Spectrum" of Breast Cancer Disparities$441,454
U01 · FY2009 · CA · contact PI
Cancer Control at the Intersection of Aging Research$158,250
K05 · FY2009 · CA · contact PI
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?$668,007
R01 · FY2008 · CA · contact PI
Using Physiological Age to Predict Chemotherapy Toxicity$580,144
R01 · FY2008 · CA · contact PI
CISNET: The "Spectrum" of Breast Cancer Disparities$242,189
U01 · FY2008 · CA · contact PI
Cancer Control at the Intersection of Aging Research$157,364
K05 · FY2008 · CA · contact PI
Using Physiological Age to Predict Chemotherapy Toxicity$611,423
R01 · FY2007 · CA · contact PI
CISNET: The "Spectrum" of Breast Cancer Disparities$344,494
U01 · FY2007 · CA · contact PI
Cancer Control at the Intersection of Aging Research$154,827
K05 · FY2007 · CA · contact PI
CISNET: The "Spectrum" of Breast Cancer Disparities$230,214
U01 · FY2006 · CA · contact PI
Cancer Control at the Intersection of Aging Research$138,622
K05 · FY2006 · CA · contact PI
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$550,574
U10 · FY2005 · CA
CISNET: The "Spectrum" of Breast Cancer Disparities$249,324
U01 · FY2005 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$161,171
U10 · FY2005 · CA
Cancer Control at the Intersection of Aging Research$138,622
K05 · FY2005 · CA
NIA CALGB - Foreign Accrual$0
U10 · FY2005 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$499,659
U10 · FY2004 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$162,688
U10 · FY2004 · CA
Cancer Control at the Intersection of Aging Research$138,622
K05 · FY2004 · CA
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CARE$40,352
U01 · FY2004 · CA
Foreign Accruals$0
U10 · FY2004 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$560,279
U10 · FY2003 · CA
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CARE$269,551
U01 · FY2003 · CA
Cancer Control at the Intersection of Aging Research$138,622
K05 · FY2003 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$120,497
U10 · FY2003 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$547,924
U10 · FY2002 · CA
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CARE$261,701
U01 · FY2002 · CA
Cancer Control at the Intersection of Aging Research$138,622
K05 · FY2002 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY$605,762
U10 · FY2001 · CA
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CARE$254,079
U01 · FY2001 · CA
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CARE$262,561
U01 · FY2000 · CA